Erhalte mehr Antworten von Arbeitgebern
Versende in nur wenigen Minuten einen passgenauen Lebenslauf.
Universität Basel's Infection Biology Laboratory is seeking a highly motivated PhD candidate to investigate T-cell immunity in EBV-associated cancers. You will develop patient-derived tumor models and apply CRISPR/Cas9, immunopeptidomics, and single-cell multiomics to advance translational cancer immunotherapy.
The project sits within a translational program with clinical collaboration, GMP facilities, and opportunities to present at conferences and publish in high-impact journals.
As a joint venture of the University of Basel and the University Hospitals Basel, the Department of Biomedicine (DBM) brings together basic and clinical scientists to advance the understanding of health and disease.
We are home to more than 67 research groups and over 800 employees across six locations in the heart of Basel. Our collaborative and international environment fosters innovation, excellence, and impactful research.
The Infection Biology, led by Prof. Nina Khanna Gremmelmaier, is looking for a fully funded PHD position.
Join our community and help shape the future of biomedicine.
The Infection Biology Laboratory studies immune responses to infectious diseases and virus-associated malignancies with the goal of developing next-generation cellular immunotherapies. We are seeking a highly motivated PhD candidate to join an interdisciplinary research project investigating T-cell immunity in Epstein-Barr virus (EBV)-associated cancers.
Despite the success of EBV-specific T-cell therapies in selected malignancies, therapeutic efficacy remains limited in tumors expressing only a restricted repertoire of viral antigens. This project aims to identify novel tumor-reactive T-cell receptors (TCRs) that can be translated into next-generation adoptive T-cell therapies.
The successful candidate will develop patient-derived tumor models and combine them with cutting-edge technologies including CRISPR/Cas9 genome engineering, immunopeptidomics, single-cell multiomics, and functional immunology. The project is embedded in a translational research program that develops virus-specific T-cell therapies with clinical application through close collaboration with clinicians, GMP manufacturing facilities, and clinical trial units. It therefore offers a unique opportunity to gain expertise across the entire translational pipeline - from mechanistic discovery to cellular therapy development and clinical implementation.
As part of this interdisciplinary project, you will: